As cell therapy and regenerative medicine continue to accelerate, 

cold-chain stability has become a baseline requirement in process design.

In ultra-low temperature processes, 

every unnecessary freeze–thaw cycle can lead to loss of biological activity — and even batch risk.

Tubing is often overlooked, yet it remains one of the most critical components.

DuPont LIVEO Pharma TPE Ultra-Low Temperature Tubing

• Designed to withstand –80 °C ultra-low temperature conditions

• Validated through multiple freeze–thaw cycle testing

• Compliant with key USP regulatory requirements

• Non-adsorptive to preservatives

• One of the few TPE tubings suitable for ultra-low temperature processing

• Ideal for biological reagents, cell therapy, and mRNA vaccine manufacturing

https://youtube.com/shorts/s8KPthJv7_c

Explore real-world performance under ultra-low temperature conditions.

Let DuPont × Essence Plus support your process design by:

Locking in stability

Protecting your R&D outcomes

And ensuring confidence in regulatory compliance and quality.

Let’s connect at service@healthcare-plus.com.tw.